Successful resumption of trimethoprim-sulfamethoxazole after oral desensitisation in patients with chronic granulomatous disease.
Two patients with chronic granulomatous disease who had previously been intolerant to trimethoprim-sulfamethoxazole because of various adverse reactions completed a desensitisation protocol with a favourable clinical outcome.
Hasui
Masafumi
M
Department of Paediatrics, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka 570-8506, Japan. hasuim@takii.kmu.ac.jp
Kotera
Fumiko
F
Tsuji
Shoji
S
Yamamoto
Akemi
A
Taniuchi
Shoichiro
S
Fujikawa
Yasuhiro
Y
Nakajima
Mitsuru
M
Yoshioka
Akira
A
Kobayashi
Yohnosuke
Y
D000293:Adolescent; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D006105:Granulomatous Disease, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination